Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Consolidated Net Income (2016 - 2025)

Tg Therapeutics has reported Consolidated Net Income over the past 10 years, most recently at -$84.7 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at -$84.7 million for Q4 2025, down 449.72% from a year ago — trailing twelve months through Dec 2025 was $339.5 million (up 1300.11% YoY), and the annual figure for FY2025 was $339.4 million, up 1299.23%.
  • Consolidated Net Income for Q4 2025 was -$84.7 million at Tg Therapeutics, down from $390.9 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for TGTX hit a ceiling of $390.9 million in Q3 2025 and a floor of -$94.0 million in Q4 2021.
  • Median Consolidated Net Income over the past 5 years was -$37.9 million (2022), compared with a mean of -$10.1 million.
  • Peak annual rise in Consolidated Net Income hit 10005.87% in 2025, while the deepest fall reached 449.72% in 2025.
  • Tg Therapeutics' Consolidated Net Income stood at -$94.0 million in 2021, then rose by 14.49% to -$80.4 million in 2022, then skyrocketed by 82.07% to -$14.4 million in 2023, then skyrocketed by 267.92% to $24.2 million in 2024, then tumbled by 449.72% to -$84.7 million in 2025.
  • The last three reported values for Consolidated Net Income were -$84.7 million (Q4 2025), $390.9 million (Q3 2025), and $28.2 million (Q2 2025) per Business Quant data.